申请人:——
公开号:US20020183318A1
公开(公告)日:2002-12-05
A marked up versions of the abstract showing insertions and deletions are included in Appendix A.
Please add the following abstract:
Compounds having the formula (I)
Z—OCH
2
—C≡CCH
2
—NRR
1
(I)
or a pharmaceutically acceptable salt or solvate thereof wherein Z can represent the formula (1A) or (1B).
1
The compounds possess antiproliferative activity and are useful as modulators of multiple drug resistance in cancer chemotherapy. The compounds may also be useful for the manufacture of a medicament for the treatment or prevention of neoplasms, menopausal disorders and osteoporosis.
摘要的标记版本,显示插入和删除,已包含在附录A中。请添加以下摘要:具有化学式(I)Z—OCH2—C≡CCH2—NRR1(I)或其药用可接受的盐或溶剂,其中Z可以表示化学式(1A)或(1B)。这些化合物具有抗增殖活性,并可用作癌症化疗中多药耐药的调节剂。这些化合物还可能用于制造用于治疗或预防肿瘤、更年期障碍和骨质疏松症的药物。